Andrews HN - Search Results

1

Role played by BRCA1 in regulating the cellular response to stress.

Gilmore PM, Quinn JE, Mullan PB, Andrews HN, McCabe N, Carty M, Kennedy RD, Harkin DP. Gilmore PM, et al. Among authors: andrews hn. Biochem Soc Trans. 2003 Feb;31(Pt 1):257-62. Biochem Soc Trans. 2003. PMID: 12546697 Review.

2

BRCA1 regulates the interferon gamma-mediated apoptotic response.

Andrews HN, Mullan PB, McWilliams S, Sebelova S, Quinn JE, Gilmore PM, McCabe N, Pace A, Koller B, Johnston PG, Haber DA, Harkin DP. Andrews HN, et al. J Biol Chem. 2002 Jul 19;277(29):26225-32. doi: 10.1074/jbc.M201316200. Epub 2002 May 13. J Biol Chem. 2002. PMID: 12011077 Free article.

3

BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3.

Gilmore PM, McCabe N, Quinn JE, Kennedy RD, Gorski JJ, Andrews HN, McWilliams S, Carty M, Mullan PB, Duprex WP, Liu ET, Johnston PG, Harkin DP. Gilmore PM, et al. Among authors: andrews hn. Cancer Res. 2004 Jun 15;64(12):4148-54. doi: 10.1158/0008-5472.CAN-03-4080. Cancer Res. 2004. PMID: 15205325

4

BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.

Mullan PB, Quinn JE, Gilmore PM, McWilliams S, Andrews H, Gervin C, McCabe N, McKenna S, White P, Song YH, Maheswaran S, Liu E, Haber DA, Johnston PG, Harkin DP. Mullan PB, et al. Oncogene. 2001 Sep 27;20(43):6123-31. doi: 10.1038/sj.onc.1204712. Oncogene. 2001. PMID: 11593420

5

Uncovering BRCA1-regulated signalling pathways by microarray-based expression profiling.

Mullan PB, McWilliams S, Quinn J, Andrews H, Gilmore P, McCabe N, McKenna S, Harkin DP. Mullan PB, et al. Biochem Soc Trans. 2001 Nov;29(Pt 6):678-83. doi: 10.1042/0300-5127:0290678. Biochem Soc Trans. 2001. PMID: 11709053 Review.

6

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.

Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE. Nielsen TO, et al. Among authors: andrews hn. Cancer Res. 2004 Jan 1;64(1):286-91. doi: 10.1158/0008-5472.can-03-1242. Cancer Res. 2004. PMID: 14729636

7

Celecoxib inhibits urokinase-type plasminogen activator (uPA) production in MDA-MB-231 breast cancer cells.

Andrews HN, Habibi G, Kucab JE, Dunn SE. Andrews HN, et al. Breast Cancer Res Treat. 2005 Nov;94(1):47-52. doi: 10.1007/s10549-005-6941-5. Breast Cancer Res Treat. 2005. PMID: 16172791

8

Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK).

Santos ND, Habibi G, Wang M, Law JH, Andrews HN, Wei D, Triche T, Dedhar S, Dunn SE. Santos ND, et al. Among authors: andrews hn. Transl Oncogenomics. 2007 Jul 23;2:85-97. Print 2007. Transl Oncogenomics. 2007. PMID: 23645983 Free PMC article.

9

Effect of social housing condition on heat shock protein (HSP) expression in the Shionogi mouse mammary carcinoma (SC115).

Andrews HN, Kerr LR, Strange KS, Emerman JT, Weinberg J. Andrews HN, et al. Breast Cancer Res Treat. 2000 Feb;59(3):199-209. doi: 10.1023/a:1006314010958. Breast Cancer Res Treat. 2000. PMID: 10832590

10

Psychosocial stressors and mammary tumor growth: an animal model.

Strange KS, Kerr LR, Andrews HN, Emerman JT, Weinberg J. Strange KS, et al. Among authors: andrews hn. Neurotoxicol Teratol. 2000 Jan-Feb;22(1):89-102. doi: 10.1016/s0892-0362(99)00049-5. Neurotoxicol Teratol. 2000. PMID: 10642118 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters